Boston Scientific
(NYSE: BSX)
is seeking approval from the city of Maple Grove to add another 300,000 ft² to its recently opened 400,000 ft² division headquarters in the northwest Minneapolis suburb.
The Maple Grove Planning Commission voted 6-0 on Jan. 12 to recommend the Minnesota Science and Technology Center – Arbor Lakes Phase II to the City Council, which meets next week.
According to documents filed with the planning commission by developer Ryan Cos., the four-story addition will wrap along the south side of the site, extending Boston Scientific’s frontage along Interstate 94.
The Arbor Lakes campus expansion will include training areas, a cafeteria, a fitness center, and a lab space on the first floor, with labs and office spaces on the second through fourth floors.
Sustainability features that could be incorporated at the site include electrical vehicle charging stations, solar panels, geothermal wells, on-site infiltration for stormwater runoffs, and native and drought-tolerant landscaping. As with all its Minnesota sites, Boston Scientific is also planning pollinator-friendly plantings and beehives, which it installs through a partnership with the University of Minnesota.
During the planning commission meeting, Emily Colletti, Boston Scientific senior director of facilities, global workforce strategy, and EHS, described the first phase of the project as a tremendous success, with all employees moved over the past three months and an official ribbon-cutting held in October 2025.
In December, the company spent $188.8 million to buy the property at 1 Boston Scientific Way from Black Bear MN LLC, an entity related to the developer Ryan Cos.
The present facility primarily serves non-manufacturing employees working in the company’s Cardiovascular (Peripheral Interventions and Interventional Cardiology Therapies) businesses.
Said Colletti: “Our employees are so excited to be at the new site.”
MassDevice‘s sibling publication R&D World recently spoke with Stephanie Board, Boston Scientific group VP of Interventional Cardiology & Vascular Therapies, about how the present Maple Grove facility was designed to be reconfigurable and stay out of researchers’ way. Read the full R&D World story here.
